Dublin, Nov. 22, 2013 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/hvm8ws/biomaterials)
has announced the addition of the "Biomaterials
Market [By Products (Polymers, Metals, Ceramics, Natural
Biomaterials) & Applications (Cardiovascular, Orthopedic,
Dental, Plastic Surgery, Wound Healing, Tissue Engineering,
Ophthalmology, Neurology Disorders)] Global Forecasts to 2017"
report to their offering.
A biomaterial is a natural or synthetic material suited to replace
or treat natural body tissues and organs on interaction with
biological systems. It traces its history to more than 2000 years
ago, when Romans, Chinese, and Aztecs used gold for dental
applications. Biomaterials, which are also biocompatible, have
since been adapted, improvised, and technically enabled to improve
body functions and replace damaged tissues. They have evolved to
include biodegradable materials that are easily dissolved in the
body. Advances in technology and the emergence of innovative
biomaterial products have enhanced their performance and
applications.
The global biomaterial market is estimated to reach $88.4 billion
by 2017 from $44.0 billion in 2012, growing at a CAGR of 15%.
Increased investments, funding and grants by government bodies
worldwide, incessant rise in the number of collaborations,
conferences and research-related activities, technological
advancements, increasing applications of biomaterials, and growing
number of elderly people are the major factors propelling the
growth of the biomaterial market globally. Immunological and
inflammatory reactions, stringent regulatory systems, issue of
fracture fatigue and wear and reimbursement concerns are the major
deterrents curbing the biomaterial market.
The global
biomaterial market witnesses a plethora of growth
opportunities. Novel developments of biomaterial for wound healing,
plastic surgery, tissue engineering, ophthalmology, and neurology,
colossal pool of cardiac patients in Asia, rise of biomaterial
market in China and Taiwan, and increased conferences and
research-related activities in RoW countries are major factors
influencing the growth of the biomaterial market. The burning
issues affecting the growth of biomaterial market are challenges to
tissue engineering and effect on suppliers by the Biomaterials
Access Assurance Act.
This research report categorizes and analyzes the global
biomaterial market under two broad segments - type and application.
Both of these markets are broken down into segments and
sub-segments, providing exhaustive value analysis for the years
2010, 2011, 2012, and forecast to 2017. Each market is
comprehensively analyzed at a granular level by geography (North
America, Europe, Asia, and Rest of the World) to provide in-depth
information on the global scenario.
Key Topics Covered:
1 Introduction
2 Executive Summary
3 Market Overview
4 Global Biomaterial Market, By Type
5 Global Biomaterial Market, By Application
6 Geographic Analysis
7 Competitive Landscape
8 Company Profiles
Companies Mentioned
- Basf Se
- Bayer Ag
- Biomet, Inc.
- Cam Bioceramics Bv
- Collagen Natrix, Inc.
- Covalon Technologies Ltd.
- Dentsply International, Inc.
- Depuy Orthopaedics, Inc.
- Hycail Finland Oy
- Invibio Ltd.
- Kyocera Corporation
- Landec Corporation
- Materion Corporation
- Orthovita, Inc.
- Osteotech, Inc.
- Purac Ciomaterials (A Csm Company)
- Sigma-Aldrich Corporation
- Starch Medical, Inc.
- Wright Medical Group, Inc.
For more information visit http://www.researchandmarkets.com/research/hvm8ws/biomaterials
Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector:
Biotechnology